MEDIAN TECHNOLOGIES (ALMDT.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALMDT - FR0011049824 - Common Stock
2.945 EUR
-0.15 (-4.69%)
Overall ALMDT gets a fundamental rating of 2 out of 10. We evaluated ALMDT against 11 industry peers in the Health Care Technology industry. ALMDT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ALMDT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ALMDT had negative earnings in the past year.
ALMDT had a negative operating cash flow in the past year.
In the past 5 years ALMDT always reported negative net income.
In the past 5 years ALMDT always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -112.72%, ALMDT is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -112.72% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 102.73%, ALMDT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ALMDT's Gross Margin has been stable in the last couple of years.
ALMDT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 102.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
2. Health
2.1 Basic Checks
ALMDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMDT has more shares outstanding
ALMDT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALMDT is higher compared to a year ago.
2.2 Solvency
ALMDT has an Altman-Z score of -12.58. This is a bad value and indicates that ALMDT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -12.58, ALMDT is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -12.58 |
ROIC/WACCN/A
WACC7.3%
2.3 Liquidity
ALMDT has a Current Ratio of 0.35. This is a bad value and indicates that ALMDT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALMDT (0.35) is worse than 81.82% of its industry peers.
A Quick Ratio of 0.35 indicates that ALMDT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.35, ALMDT is doing worse than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.35 | ||
| Quick Ratio | 0.35 |
3. Growth
3.1 Past
ALMDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.04%, which is quite good.
The Revenue has been growing slightly by 6.75% in the past year.
The Revenue has been growing by 20.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)10.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%3.3%
3.2 Future
The Earnings Per Share is expected to grow by 26.15% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALMDT will show a very strong growth in Revenue. The Revenue will grow by 22.71% on average per year.
EPS Next Y46.62%
EPS Next 2Y30.92%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue Next Year3.31%
Revenue Next 2Y17.55%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALMDT. In the last year negative earnings were reported.
Also next year ALMDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALMDT's earnings are expected to grow with 26.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.92%
EPS Next 3Y26.15%
5. Dividend
5.1 Amount
ALMDT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALMDT (12/8/2025, 7:00:00 PM)
2.945
-0.15 (-4.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners10.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap108.14M
Revenue(TTM)23.31M
Net Income(TTM)-21.99M
Analysts85.45
Price Target8.81 (199.15%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-78.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.64 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS0.63
BVpS-1.1
TBVpS-1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -112.72% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 102.73% | ||
| FCFM | N/A |
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
F-Score2
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 36.46% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.35 | ||
| Quick Ratio | 0.35 | ||
| Altman-Z | -12.58 |
F-Score2
WACC7.3%
ROIC/WACCN/A
Cap/Depr(3y)102.16%
Cap/Depr(5y)84.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y46.62%
EPS Next 2Y30.92%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue 1Y (TTM)6.75%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%3.3%
Revenue Next Year3.31%
Revenue Next 2Y17.55%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y26.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.89%
EBIT Next 3Y24.38%
EBIT Next 5YN/A
FCF growth 1Y23.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3YN/A
OCF growth 5YN/A
MEDIAN TECHNOLOGIES / ALMDT.PA FAQ
What is the ChartMill fundamental rating of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA.
What is the valuation status of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?
ChartMill assigns a valuation rating of 1 / 10 to MEDIAN TECHNOLOGIES (ALMDT.PA). This can be considered as Overvalued.
What is the profitability of ALMDT stock?
MEDIAN TECHNOLOGIES (ALMDT.PA) has a profitability rating of 1 / 10.
What is the earnings growth outlook for MEDIAN TECHNOLOGIES?
The Earnings per Share (EPS) of MEDIAN TECHNOLOGIES (ALMDT.PA) is expected to grow by 46.62% in the next year.
How sustainable is the dividend of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?
The dividend rating of MEDIAN TECHNOLOGIES (ALMDT.PA) is 0 / 10 and the dividend payout ratio is 0%.